Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- AdvisorShares Psychedelics ETF AdvisorShares Trust · 24 lines · as of Mar 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | AdvisorShares Psychedelics ETF |
|---|---|
| Relmada Therapeutics Inc | 10.17 % |
| AtaiBeckley Inc | 9.92 % |
| Definium Therapeutics Inc | 8.52 % |
| Compass Pathways plc | 6.74 % |
| Neurocrine Biosciences Inc | 4.66 % |
| GH RESEARCH PLC | 4.65 % |
| Cybin Inc | 4.64 % |
| Alkermes PLC | 4.60 % |
| Johnson & Johnson | 4.56 % |
| Alto Neuroscience Inc | 4.55 % |
| Bright Minds Biosciences Inc | 4.55 % |
| AbbVie Inc | 4.47 % |
| Supernus Pharmaceuticals Inc | 4.46 % |
| NRX Therapeutics Inc | 4.42 % |
| Neuronetics Inc | 4.42 % |
| NEUPHORIA THERAPEUTICS INC | 3.12 % |
| Quantum Biopharma Ltd | 2.59 % |
| PASITHEA THERAPEUTICS CORP | 1.24 % |
| SILO PHARMA INC | 1.18 % |
| VISTAGEN THERAPEUTICS INC | 0.78 % |
| INCANNEX HEALTHCARE INC | 0.36 % |
| Numinus Wellness Inc | 0.32 % |
| ENVERIC BIOSCIENCES INC | 0.16 % |
| Clearmind Medicine Inc. | 0.04 % |
1 funds, 24 lines read.